Lindsay M. Borgeson

Healthcare Providers

• Waud Capital Partners in its acquisition of Senior Helpers, a provider home care and wellness services for seniors, from Advocate Health
• Sun Capital Partners-backed Platinum Dermatology Partners in its acquisition of Skin & Cancer Associates, a network of physicians and providers of dermatology services
• Vertava Health of Mississippi, a provider of addiction treatment and mental health services, in its sale to Bradford Health Services
• Charlesbank Capital Partners in its acquisition of Action Behavior Centers, a provider of Applied Behavior Analysis therapy, from NexPhase Capital
• Bain Capital Double Impact in its acquisition of Multi-Specialty Healthcare, an outpatient provider of post-traumatic injury care and physical rehabilitation
• The Carlyle Group in the acquisition of a majority stake in Counter Brands’ Beautycounter, a provider of clean skincare and cosmetics valued at $1 billion
• Vitruvian Partners in its acquisition of Fotona Holdings (Netherlands) B.V., a provider of lasers for aesthetic and medical applications, from AGIC Capital
• Nordic Capital in its acquisition of United Veterinary Care, a collection of veterinary practices, from Atlantic Street Capital
• Ares Management Corp. (NYSE: ARES) in its equity investment in LaserAway, a provider of aesthetic dermatology

Healthcare Technology

• Blackstone in its acquisition of M3, a provider of hospitality accounting software 
• Blackstone in its investment in Chartis, a provider of healthcare advisory services 
• Trinity Hunt Partners in its investment in Coker, a healthcare advisory firm
• GTCR-backed RevSpring, a provider of communication and payment solutions, in its sale to Frazier Healthcare Partners
• Bansk Group-backed Arcadia Consumer Healthcare in its $397 million acquisition of Avrio Health, a provider of consumer health products, from Purdue Pharma
• MultiPlan Corp. (NYSE: MPLN) in its $160 million acquisition of Benefits Science, a data and advanced analytics company
• Levine Leichtman Capital Partners in its acquisition of Technical Safety Services, a provider of testing, inspection, certification and calibration services to customers in healthcare and other life sciences, from The Edgewater Funds and JZ Partners
• TA Associates in its investment in Intelerad, a provider of enterprise medical imaging solutions
• Vestar Capital Partners-backed Mercury Healthcare, a technology and data analytics company, in its sale to WebMD Health Corp.
• Envista (NYSE: NVST) in its $600 million acquisition of Carestream Dental's Scanning Technology business, which includes intraoral scanner equipment and related software 
• Vestar Capital Partners-backed Mercury Healthcare (f/k/a Healthgrades) in its sale of Healthgrades.com, an online provider of information about physicians, hospitals and health care providers, to RV Health, a Red Ventures business
• TA Associates and Francisco Partners on their entry into a definitive agreement to jointly acquire Edifecs, a global health information technology solutions company

Life Sciences

• Peak Rock Capital in its $787.5 million acquisition of HuFriedyGroup, a provider of instruments, infection prevention products, instrument management systems and conscious sedation products for the dental industry, from STERIS (NYSE:STE)
• Owens & Minor (NYSE: OMI) in its pending $1.36 billion acquisition of Rotech Healthcare, a provider of home medical equipment
• Eli Lilly and Company (NYSE: LLY) in its $2.4 billion acquisition of DICE Therapeutics (NASDAQ: DICE), a biopharmaceutical company
• Bristol Myers Squibb (NYSE: BMY) in its $5.8 billion acquisition of Mirati Therapeutics (NASDAQ: MRTX), a commercial stage research and development biotechnology company
• Owens & Minor (NYSE: OMI) in its $1.6 billion acquisition of Apria (NASDAQ: APR), a provider of integrated home healthcare equipment and related services
• Novo Holdings in its acquisition of Medical Knowledge Group, an analytics-driven drug commercialization platform servicing the biopharmaceutical industry, from Court Square Capital and Aisling Capital
• Envista (NYSE: NVST) in its acquisition of Osteogenics, a developer of regenerative solutions for periodontists, oral & maxillofacial surgeons and clinicians involved in implant dentistry
• Pamplona Capital Management-backed Parexel, a clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance patient health, in its $8.5 billion sale to EQT Private Equity and Goldman Sachs Asset Management

Privacy

• The Susan G. Komen Foundation providing ongoing healthcare privacy counsel related to the implementation of programming initiatives (including research efforts, patient navigator programs, and programs designed to increase patient access to breast cancer screenings). Lindsay has also advised on ongoing developmental operations

Restructuring

• Rite Aid Corporation (“Rite Aid”) and 119 of its affiliates in their Chapter 11 cases in the U.S. Bankruptcy Court for the District of New Jersey. Rite Aid entered its Chapter 11 cases with $3.45 billion in debtor-in possession financing. Following months of negotiations including court-ordered mediation with all of Rite Aid’s key stakeholders, as well as several bet-the-company disputes and obtaining an additional $75 million in debtor-in-possession financing later in the cases, Rite Aid was able to delever its balance sheet by approximately $2 billion through a recapitalization transaction with its senior secured noteholders and resolve more than $2.5 billion in pending and threatened litigation. Rite Aid emerged from Chapter 11 on August 30, 2024 with $2.975 billion in committed exit financing, a new go-forward supply contract with McKesson (Rite Aid’s largest vendor and the provider of 98% of Rite Aid’s just-in-time prescriptions), settlement agreements or controlled substance injunctive terms with the Department of Justice and 15 states in which Rite Aid conducts business, and a leaner, more efficient real estate footprint.
• Envision Healthcare Corp. and 216 of its affiliates in the commencement of pre-arranged Chapter 11 cases. Envision is a leading national medical group that employs or partners with more than 21,000 clinicians and provides care to patients across the U.S., with nearly 30 million patient visits each year. The two restructuring support agreements (on account of its two credit silos) contemplate, among other things, a collective deleveraging of approximately $7.4 billion of secured and unsecured debt and the separation of Envision’s physician services and ambulatory surgical center businesses
• Center for Autism and Related Disorders, LLC (“CARD”) and four of its affiliates in their Chapter 11 cases in the U.S. Bankruptcy Court for the Southern District of Texas. CARD is one of the nation’s largest treatment providers for individuals diagnosed with autism spectrum disorder. Prior to filing for Chapter 11, CARD entered into a stalking horse asset purchase agreement for a going-concern sale of substantially all of CARD’s assets. CARD intends to use the Chapter 11 cases to run a competitive sale and bidding process to maximize enterprise value. CARD entered the Chapter 11 cases with a new money, delayed draw term loan debtor-in-possession financing facility from the company’s prepetition credit facility lenders

Epstein Becker & Green, P.C.

Winston & Strawn, LLP